No photo available.

Diane M. Thiboutot, M.D.

Professor of Dermatology Vice-Chair for Research for Dermatology Director of Clinical & Transitional Science Research Education

Office Information

Penn State Hershey Dermatology
100 Campus Drive, Entrance 3, Suite 100
Hershey, PA 17033
Tel: 800-243-1455 / 717-531-6820 / (717) 531-6820 Fax: 717-531-4702



Patient Services Provided

Acne Botox injections Juvederm

Practice Locations

Professional Education

Residency, Dermatology, Penn State Milton S. Hershey Medical Center (1992) M.D., Penn State Hershey College of Medicine (1988)

Research Interests

Acne Vulgaris- We are continuously conducting mild,moderate and/or severe acne vularis studies to enhance the treatment options for teens and adults who suffer from acne. The studies have involved several combinations of investigational and/or FDA approved topical and/or oral medication.

Rosacea - Our clinical trials office  has fully executed research studies applying topical and oral medications both Investigational and FDA approved products. Since there is no cure, there is a necessity to continue research.


Lumsden KR, Nelson AM, Dispenza MC, Gilliland KL, Cong Z, Zaenglein AL, Thiboutot DM
Isotretinoin increases skin-surface levels of neutrophil gelatinase-associated lipocalin in patients treated for sever acne.
Br J Dermatol. 2011 Aug;165(2):302-10
Nelson AM, Cong Z, Gilliland KL, Thiboutot DM
TRAIL contributes to the apoptotic effect of 13-cis retinoic acid in human sebaceous gland cells
Br J Dermatol. May12
Thiboutot DM
Rethinking treatment of acne in the severe patient
Thiboutot DM
Dermatologists Do Not Yet Fully Understand the Clinical Significance of Antibiotic Use and Bacterial Resistance in Patients With Acne: Comment on
Arch Dermatol. 2011 UG;147(8):921-2
Thiboutot Dm
Introduction. Challenges in managing acne patients.
J Drugs Dermatol. 2011 JUn1;10(6):s7
Show all publications »